Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 694
Selected: 0
NCT IDTitle
NCT01131351Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
NCT07225712A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
NCT01184807Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
NCT01074294Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT03303092Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine
NCT04786730A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
NCT02087007A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT01444885Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT01456897A Long-term Trial of OPC-34712 in Patients With Schizophrenia
NCT01628926A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT00233363Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT03772041Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT00283179Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
NCT07105124Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject
NCT00845988Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
NCT04782258A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT04865835A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.
NCT01683058Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
NCT00043758Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT03406286Samsca PMS in ADPKD Patients
NCT00317356A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
NCT04784442A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
NCT01397786Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
NCT05848700A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
NCT01111565Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT03487198The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
NCT01623154POCone-UBiT-IR300 Pediatric Comparison Study
NCT00110461Aripiprazole in Children and Adolescents With Bipolar I Disorder
NCT02827513A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects
NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
NCT00544869A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)
NCT01710709Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT04770285Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
NCT01737931A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject
NCT02160145Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
NCT01344876Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
NCT00097266Study of Aripiprazole in Patients With Acute Bipolar Mania
NCT01590901Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT01261481Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact
NCT01942161A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT00132886Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT03872596Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCT00338273A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT01423903Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
NCT01210560Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD
NCT02364947A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)